Asterias Biotherapeutics, Inc. announced today that it received approval to list its Series A common stock on the NYSE MKT under the ticker symbol "AST." The Company's shares are expected to begin trading on the NYSE MKT on October 8, 2014.
http://ift.tt/1s4LB5U
http://ift.tt/1s4LB5U
No comments:
Post a Comment